Page last updated: 2024-11-05

trazodone and Hepatitis, Chronic

trazodone has been researched along with Hepatitis, Chronic in 1 studies

Trazodone: A serotonin uptake inhibitor that is used as an antidepressive agent. It has been shown to be effective in patients with major depressive disorders and other subsets of depressive disorders. It is generally more useful in depressive disorders associated with insomnia and anxiety. This drug does not aggravate psychotic symptoms in patients with schizophrenia or schizoaffective disorders. (From AMA Drug Evaluations Annual, 1994, p309)
trazodone : An N-arylpiperazine in which one nitrogen is substituted by a 3-chlorophenyl group, while the other is substituted by a 3-(3-oxo[1,2,4]triazolo[4,3-a]pyridin-2(3H)-yl)propyl group.

Hepatitis, Chronic: INFLAMMATION of the LIVER with ongoing hepatocellular injury for 6 months or more, characterized by NECROSIS of HEPATOCYTES and inflammatory cell (LEUKOCYTES) infiltration. Chronic hepatitis can be caused by viruses, medications, autoimmune diseases, and other unknown factors.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Beck, PL1
Bridges, RJ1
Demetrick, DJ1
Kelly, JK1
Lee, SS1

Other Studies

1 other study available for trazodone and Hepatitis, Chronic

ArticleYear
Chronic active hepatitis associated with trazodone therapy.
    Annals of internal medicine, 1993, May-15, Volume: 118, Issue:10

    Topics: Aged; Chemical and Drug Induced Liver Injury; Chemical and Drug Induced Liver Injury, Chronic; Femal

1993